HIGHLIGHTS
- who: Jakub Wesolowski et al. from the Department of Pharmacodynamics, Faculty of Pharmacy, Medical University in Bialystok, Bialystok, Poland have published the article: Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer, in the Journal: Cancers 2022, 3860 of /2022/
- what: In this review, the authors aim to shed a light on immunotherapeutic opportunities using monoclonal_antibodies approved by the U.S. Food and Drug Administration (FDA) in the treatment of TNBCs, such as atezolizumab and pembrolizumab, An in_vitro study was carried out to evaluate the avelumab-mediated ADCC on TNBC line cells, whose PD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.